Ten Genes for Inherited Breast Cancer

Biallelic Inactivation of <i>BRCA2</i> in Fanconi Anemia

Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149 · see citing works

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104 · see citing works

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,002 · see citing works

Essential role for nuclear PTEN in maintaining chromosomal integrity

Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979 · see citing works

Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2

Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861 · see citing works

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

The Breast Cancer Susceptibility Collaboration (UK), Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1902 · Cited by 746 · see citing works

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

Renwick, A., Thompson, D. J., Seal, S., Kelly, P. F., Chagtai, T., Ahmed, M., North, B. V., Jayatilake, H., Barfoot, R., Spanova, K., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743 · see citing works

Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer

Walsh, T., Casadei, S., Coats, K. H., Swisher, E. M., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J. B., Lee, M. K., Čierniková, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 664 · see citing works

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642 · see citing works

A recurrent mutation in PALB2 in Finnish cancer families

Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A. H., Pylkäs, K., Karppinen, S., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466 · see citing works

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

Xia, B., Dorsman, J. C., Ameziane, N., de Vries, Y., Rooimans, M. A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1942 · Cited by 465 · see citing works

BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ

Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396 · see citing works

Molecular pathogenesis of Fanconi anemia: recent progress

Taniguchi, T., & D’Andrea, A. D. (2006) · Blood · doi:10.1182/blood-2005-10-4240 · Cited by 387 · see citing works

RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability

Heikkinen, K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi360 · Cited by 208 · see citing works

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

Levy‐Lahad, E., Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., Kasinetz, L., Catane, R., Kaufman, B., Beller, U., Renbaum, P., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051624098 · Cited by 182 · see citing works

The DNA Damage Response: Making It Safe to Play with Knives

Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368 · see citing works

Genetic Heterogeneity in Human Disease

McClellan, J., & King, M.-C. (2010) · Cell · doi:10.1016/j.cell.2010.03.032 · Cited by 981 · see citing works

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007

Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thurlimann, B. J. K., & Senn, H.-J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm271 · Cited by 932 · see citing works

Repair of Strand Breaks by Homologous RecombinationPreprint

Jasin, M., & Rothstein, R. J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012740 · Cited by 877 · see citing works

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H., et al. (2010) · Nature Genetics · doi:10.1038/ng.569 · Cited by 743 · see citing works

MicroRNA function in cancer: oncogene or a tumor suppressor?

Shenouda, S. K., & Alahari, S. K. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9188-5 · Cited by 677 · see citing works

A survey of tools for variant analysis of next-generation genome sequencing data

Pabinger, S., Dander, A., Fischer, M., Snajder, R., Sperk, M., Efremova, M., Krabichler, B., Speicher, M. R., Zschocke, J., & Trajanoski, Z. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbs086 · Cited by 595 · see citing works

In search of breast cancer culprits: suspecting the suspected and the unsuspected.

Subik, K., Lee, J.-F., Baxter, L., Strzepek, T., Costello, D., Crowley, P., Xing, L., Hung, M., Bonfiglio, T. A., Hicks, D. G., et al. (2008) · PubMed Central · Cited by 577 · see citing works

Breast Cancer Epidemiology and Risk Factors

Rojas, K. E., & Stuckey, A. R. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000239 · Cited by 573 · see citing works

Oncogenes and Tumor Suppressor GenesPreprint

Lee, E. Y., & Muller, W. J. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003236 · Cited by 515 · see citing works

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

Walsh, T., Lee, M. K., Casadei, S., Thornton, A., Stray, S. M., Pennil, C. C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 485 · see citing works

Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models

Amir, E., Freedman, O. C., Šeruga, B., & Evans, D. G. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq088 · Cited by 463 · see citing works

Mechanisms of double-strand break repair in somatic mammalian cells

Hartlerode, A. J., & Scully, R. (2009) · Biochemical Journal · doi:10.1042/bj20090942 · Cited by 365 · see citing works

Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer

Bao, Y., Wang, L., Shi, L., Yun, F., Liu, X., Chen, Y., Chen, C., Ren, Y., & Jia, Y. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0162-0 · Cited by 354 · see citing works

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons

Manahan, E. R., Kuerer, H. M., Sebastian, M., Hughes, K. S., Boughey, J. C., Euhus, D., Boolbol, S. K., & Taylor, W. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07549-8 · Cited by 347 · see citing works

Association genetics of complex traits in plants

Ingvarsson, P. K., & Street, N. R. (2010) · New Phytologist · doi:10.1111/j.1469-8137.2010.03593.x · Cited by 334 · see citing works

Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53 –Mediated Mouse Mammary Tumors

Shafee, N., Smith, C. R., Wei, S., Kim, Y. H., Mills, G. B., Hortobágyi, G. N., Stanbridge, E. J., & Lee, E. Y.-H. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5480 · Cited by 305 · see citing works

Nuclear Receptor Coregulators and Human Disease

Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 303 · see citing works

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

Hollestelle, A., Nagel, J. H. A., Smid, M., Lam, S., Elstrodt, F., Wasielewski, M., Ng, S. S., French, P. J., Peeters, J. K., Rozendaal, M. J., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0460-8 · Cited by 296 · see citing works

DNA Double-Strand Break Repair as Determinant of Cellular Radiosensitivity to Killing and Target in Radiation Therapy

Mladenov, E., Magin, S., Soni, A., & Iliakis, G. E. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00113 · Cited by 292 · see citing works

Family-based designs for genome-wide association studies

Ott, J., Kamatani, Y., & Lathrop, M. G. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2989 · Cited by 268 · see citing works

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review

Ludwig, K. K., Neuner, J., Butler, A., Geurts, J. L., & Kong, A. L. (2016) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2016.06.010 · Cited by 243 · see citing works

Pharmacogenetics: Implications of race and ethnicity on defining genetic profiles for personalized medicine

Ortega, V. E., & Meyers, D. A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.040 · Cited by 237 · see citing works

Genomic Instability and Cancer

Dai, Y. Y. W. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000165 · Cited by 235 · see citing works

RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear fociPreprint

Hu, Y., Scully, R., Sobhian, B., Xie, A., Shestakova, E. A., & Livingston, D. M. (2011) · Genes & Development · doi:10.1101/gad.2011011 · Cited by 232 · see citing works

DNA Damage and Repair: From Molecular Mechanisms to Health Implications

Fabio Altieri, F., Grillo, C., Maceroni, M., & Chichiarelli, S. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1830 · Cited by 212 · see citing works

Breast cancer susceptibility: current knowledge and implications for genetic counselling

Ripperger, T., Gadzicki, D., Meindl, A., & Schlegelberger, B. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.212 · Cited by 212 · see citing works

Human diseases through the lens of network biology

Furlong, L. I. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.11.004 · Cited by 194 · see citing works

Epidemiology of Breast Cancer

Ban, K. A., & Godellas, C. V. (2014) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2014.03.011 · Cited by 189 · see citing works

BRCA1 haploinsufficiency for replication stress suppression in primary cells

Pathania, S., Bade, S., Guillou, M. L., Burke, K. A., Reed, R., Bowman-Colin, C., Su, Y., Ting, D. T., Polyák, K., Richardson, A. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6496 · Cited by 178 · see citing works

PARP1-Driven Poly-ADP-Ribosylation Regulates BRCA1 Function in Homologous Recombination–Mediated DNA Repair

Hu, Y., Petit, S. A., Ficarro, S. B., Toomire, K. J., Xie, A., Lim, E., Cao, S. A., Park, E., Eck, M. J., Scully, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0891 · Cited by 171 · see citing works

Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2

Dray, E. V., Etchin, J., Wiese, C., Saro, D., Williams, G. J., Hammel, M., Yu, X., Galkin, V. E., Liu, D., Tsai, M.-S., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1916 · Cited by 168 · see citing works

The importance of BRCA1 and BRCA2 genes mutations in breast cancer development.

Mehrgou, A., & Akouchekian, M. (2016) · PubMed Central · Cited by 166 · see citing works

Hereditary breast and ovarian cancer susceptibility genes (Review)

Kobayashi, H., Ohno, S., Sasaki, Y., & Matsuura, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2541 · Cited by 163 · see citing works

Mechanisms of BRCA1 Tumor Suppression

Silver, D. P., & Livingston, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0221 · Cited by 159 · see citing works

The causes of replication stress and their consequences on genome stability and cell fate

Magdalou, I., López, B. S., Pasero, P., & Lambert, S. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.04.035 · Cited by 157 · see citing works

Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer‐predisposing gene

Bártková, J., Tommiska, J., Oplustilova, L., Aaltonen, K., Tamminen, A., Heikkinen, T., Mistrík, M., Aittomäki, K., BLOMQVIST, C. P., Heikkilä, P., et al. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.09.007 · Cited by 156 · see citing works

PALB2 mutations in familial breast and pancreatic cancer

Hofstatter, E. W., Domchek, S. M., Miron, A., Garber, J. E., Wang, M., Componeschi, K. P., Boghossian, L., Miron, P. L., Nathanson, K. L., & Tung, N. (2011) · Familial Cancer · doi:10.1007/s10689-011-9426-1 · Cited by 155 · see citing works

Mammary Tumor Development in Dogs Is Associated with BRCA1 and BRCA2

Rivera, P., Melin, M., Biagi, T., Fall, T., Häggström, J. U., Lindblad‐Toh, K., & von Euler, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1725 · Cited by 150 · see citing works

Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer

Gray, M., Meehan, J., Martínez-Pérez, C., Kay, C., Turnbull, A., Morrison, L. R., Pang, L. Y., & Argyle, D. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00617 · Cited by 148 · see citing works

DNA helicase and helicase-nuclease enzymes with a conserved iron-sulfur cluster

Wu, Y., & Brosh, R. M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks039 · Cited by 142 · see citing works

Is homologous recombination really an error-free process?

Guirouilh‐Barbat, J., Lambert, S., Bertrand, P., & López, B. S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00175 · Cited by 142 · see citing works

Detecting rare variants for complex traits using family and unrelated data

Zhu, X., Feng, T., Li, Y., Lu, Q. L., & Elston, R. C. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20449 · Cited by 134 · see citing works

Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2 -Associated Hereditary Breast Cancer

Huo, Y., Cai, H., Teplova, I., Bowman-Colin, C., Chen, G., Price, S. M., Barnard, N., Ganesan, S., Karantza, V., White, E., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0011 · Cited by 132 · see citing works

AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51

Plo, I., Laulier, C., Gauthier, L., Lebrun, F., Calvo, F. M., & López, B. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0861 · Cited by 132 · see citing works

Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair

Park, J.-Y., Singh, T. R., Nassar, N., Zhang, F., Freund, M., Hanenberg, H., Meetei, A. R., & Andreassen, P. R. (2014) · Oncogene · doi:10.1038/onc.2013.421 · Cited by 130 · see citing works

Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics

Larsen, M. J., Thomassen, M., Gerdes, A., & Kruse, T. A. (2014) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s18715 · Cited by 117 · see citing works

Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer

Kapoor, N. S., Curcio, L. D., Blakemore, C. A., Bremner, A. K., McFarland, R. E., West, J. G., & Banks, K. C. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4754-2 · Cited by 111 · see citing works

An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset

Song, F., Zheng, H., Liu, B., Wei, S., Dai, H., Zhang, L., Calin, G. A., Hao, X., Wei, Q., Zhang, W., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0826 · Cited by 111 · see citing works

Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability

Schild, D., & Wiese, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1063 · Cited by 110 · see citing works

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study

Ortega, V. E., Hawkins, G. A., Moore, W. C., Hastie, A. T., Ampleford, E. J., Busse, W. W., Castro, M., Chardón, D., ERZURUM, S. C., Israel, E., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70289-3 · Cited by 109 · see citing works

Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1

Cantor, S. B., & Guillemette, S. (2011) · Future Oncology · doi:10.2217/fon.10.191 · Cited by 106 · see citing works

Discovering moderate-risk breast cancer susceptibility genes

Hollestelle, A., Wasielewski, M., Martens, J. W. M., & Schutte, M. E. M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.02.009 · Cited by 105 · see citing works

Penetrance Analysis of the PALB2 c.1592delT Founder Mutation

Erkko, H., Dowty, J. G., Nikkilä, J., Syrjäkoski, K., Mannermaa, A., Pylkäs, K., Southey, M. C., Holli, K., Kallioniemi, A. H., Jukkola‐Vuorinen, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0210 · Cited by 102 · see citing works

Genomic rearrangements in BRCA1 and BRCA2: a literature review

Ewald, I. P., Ribeiro, P. L. I., Palmero, E. I., Cossio, S. L., Giugliani, R., & Ashton‐Prolla, P. (2009) · Genetics and Molecular Biology · doi:10.1590/s1415-47572009005000049 · Cited by 101 · see citing works

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

Singh, J., Thota, N., Singh, S., Padhi, S., Mohan, P., Deshwal, S., Sur, S., Ghosh, M., Agarwal, A., Sarin, R., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4726-x · Cited by 96 · see citing works

Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil

Carraro, D. M., Folgueira, M. A. A. K., Lisbôa, B. C. G., Olivieri, E. H. R., Krepischi, A. C. V., de Carvalho, A. F., Mota, L. D. D. C., Puga, R., Maciel, M. D. S., Michelli, R. A. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057581 · Cited by 96 · see citing works

Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Grabarz, A., Barascu, A., Guirouilh‐Barbat, J., & López, B. S. (2012) · Europe PMC (PubMed Central) · Cited by 93 · see citing works

A Novel Breast Cancer–Associated <i>BRIP1</i> ( <i>FANCJ/BACH1</i> ) Germ-line Mutation Impairs Protein Stability and Function

De Nicolo, A., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Di Cristofano, C., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0087 · Cited by 91 · see citing works

Cancer predisposing BARD1 mutations in breast–ovarian cancer families

Ratajska, M., Antoszewska, E., Piskorz, A., Brożek, I., Borg, Å., Kusmierek, H., Biernat, W., & Limon, J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1403-8 · Cited by 90 · see citing works

Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells

Wilhelm, T., Magdalou, I., Barascu, A., Técher, H., Debatisse, M., & López, B. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311520111 · Cited by 89 · see citing works

Breast cancer genes: beyond BRCA1 and BRCA2

Vega, A. (2013) · Frontiers in bioscience · doi:10.2741/4185 · Cited by 88 · see citing works

The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives

Cao, A., Huang, J., Hu, Z., Li, W., Ma, Z., Tang, L., Zhang, B., Su, F., Zhou, J., Di, G., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0036-z · Cited by 88 · see citing works

Nanoparticle therapeutics: Technologies and methods for overcoming cancer

Cerqueira, B. B. S., Lasham, A., Shelling, A. N., & Al‐Kassas, R. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.10.007 · Cited by 87 · see citing works

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective

Dutil, J., Golubeva, V. A., Pacheco‐Torres, A. L., Diaz-Zabala, H. J., Matta, J. L., & Monteiro, Á. N. A. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3629-3 · Cited by 87 · see citing works

Drosophila brca2 Is Required for Mitotic and Meiotic DNA Repair and Efficient Activation of the Meiotic Recombination Checkpoint

Klovstad, M. S., Abdu, U., & Schüpbach, T. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0040031 · Cited by 86 · see citing works

Cancer predisposing missense and protein truncatingBARD1mutations in non-BRCA1orBRCA2breast cancer families

Brakeleer, S. D., Grève, J. D., Loris, R., Janin, N., Lissens, W., Sermijn, E., & Teugels, E. (2010) · Human Mutation · doi:10.1002/humu.21200 · Cited by 85 · see citing works

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients

da Silva, F. C. C., Lisbôa, B. C. G., Figueiredo, M. C., Torrezan, G. T., Santos, É. M. M., Krepischi, A. C. V., Rossi, B. M., Achatz, M. I., & Carraro, D. M. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-55 · Cited by 85 · see citing works

Molecular Oncology of Breast Cancer

Joshi, H. N., & Press, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00022-2 · Cited by 82 · see citing works

Importance of DNA damage checkpoints in the pathogenesis of human cancers

Poehlmann, A., & Roessner, A. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.06.006 · Cited by 81 · see citing works

Clinical evaluation of PRMT1 gene expression in breast cancer

Mathioudaki, K., Scorilas, A., Ardavanis, A. S., Lymberi, P., Tsiambas, E., Devetzi, M., Apostolaki, A., & Talieri, M. (2011) · Tumor Biology · doi:10.1007/s13277-010-0153-2 · Cited by 81 · see citing works

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

Huijts, P. E. A., Vreeswijk, M. P. G., Kroeze‐Jansema, K., Jacobi, C. E., Seynaeve, C., Krol-Warmerdam, E. M., Wijers‐Koster, P. M., Blom, J., Pooley, K. A., Klijn, J. G. M., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1793 · Cited by 79 · see citing works

Germline mutation in the RAD51B gene confers predisposition to breast cancer

Golmard, L., Caux-Moncoutier, V., Davy, G., Ageeli, E. A., Poirot, B., Tirapo, C., Michaux, D., Barbaroux, C., d'Enghien, C. D., Nicolas, A., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-484 · Cited by 88 · see citing works

PALB2: The hub of a network of tumor suppressors involved in DNA damage responses

Park, J., Zhang, F., & Andreassen, P. R. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.003 · Cited by 78 · see citing works

Characterization of potential driver mutations involved in human breast cancer by computational approaches

Rajendran, B. K., & Deng, C.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.17225 · Cited by 73 · see citing works

Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies

Thakur, C., Qiu, Y., Fu, Y. S., Bi, Z., Zhang, W., Ji, H., & Chen, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.971288 · Cited by 73 · see citing works

Novel genetic variants in microRNA genes and familial breast cancer

Shen, J., Ambrosone, C. B., & Zhao, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.24008 · Cited by 73 · see citing works

Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer

Pan, Y., Yang, H., & Claret, F. X. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.27823 · Cited by 73 · see citing works

Bilateral breast cancers

Narod, S. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.3 · Cited by 72 · see citing works

Detecting Association of Rare and Common Variants by Testing an Optimally Weighted Combination of Variants

Sha, Q., Wang, X., Wang, X., & Zhang, S. (2012) · Genetic Epidemiology · doi:10.1002/gepi.21649 · Cited by 71 · see citing works

RAD51C Germline Mutations in Breast and Ovarian Cancer Cases from High-Risk Families

Clague, J., Wilhoite, G., Adamson, A. W., Bailis, A. M., Weitzel, J. N., & Neuhausen, S. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025632 · Cited by 71 · see citing works

Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population

Morales, S., Gulppi, F., González‐Hormazábal, P., Fernández‐Ramires, R., Bravo, T., Reyes, J. M., Gómez, F., Waugh, E., & Lilian Jara, S. (2016) · BMC Genetics · doi:10.1186/s12863-016-0415-0 · Cited by 69 · see citing works

Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network

Greenberg, R. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0154-8 · Cited by 68 · see citing works

Breast-Cancer Risk in Families with Mutations in PALB2

Thomas, P., & Brown, P. (2015) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2015.07.017 · Cited by 67 · see citing works

Genetic Epidemiology of Breast Cancer in Latin America

Zavala, V. A., Serrano-Gomez, S. J., Dutil, J., & Fejerman, L. (2019) · Genes · doi:10.3390/genes10020153 · Cited by 65 · see citing works

Mre11-Sae2 and RPA Collaborate to Prevent Palindromic Gene Amplification

Deng, S., Yin, Y. A., Petes, T. D., & Symington, L. S. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.027 · Cited by 64 · see citing works

Pathology of Hereditary Breast and Ovarian Cancer

Hodgson, A., & Turashvili, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.531790 · Cited by 64 · see citing works

The gene regulatory network for breast cancer: integrated regulatory landscape of cancer hallmarks

Emmert‐Streib, F., Simoes, R. D. M., Mullan, P. B., Haibe‐Kains, B., & Dehmer, M. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00015 · Cited by 62 · see citing works

A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response

Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 60 · see citing works

Pathogenic and likely pathogenic variants in PALB2 , CHEK2 , and other known breast cancer susceptibility genes among 1054 BRCA ‐negative Hispanics with breast cancer

Weitzel, J. N., Neuhausen, S. L., Adamson, A. W., Tao, S., Ricker, C. N., Maoz, A., Rosenblatt, M., Nehoray, B., Sand, S. R., Steele, L., et al. (2019) · Cancer · doi:10.1002/cncr.32083 · Cited by 60 · see citing works

Breast Cancer–Associated <i>Abraxas</i> Mutation Disrupts Nuclear Localization and DNA Damage Response Functions

Solyom, S., Aressy, B., Pylkäs, K., Patterson-Fortin, J., Hartikainen, J. M., Kallioniemi, A., Kauppila, S., Nikkilä, J., Kosma, V.-M., Mannermaa, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003223 · Cited by 59 · see citing works

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

Vuorela, M., Pylkäs, K., Hartikainen, J. M., Sundfeldt, K., Lindblom, A., von Wachenfeldt, A., Haanpää, M. K., Puistola, U., Rosengren, A., Anttila, M., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1677-x · Cited by 59 · see citing works

Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double‐strand break‐repair signaling pathways

Keimling, M., Volčič, M., Csernok, A., Wieland, B., Dörk, T., & Wiesmüller, L. (2011) · The FASEB Journal · doi:10.1096/fj.11-185546 · Cited by 59 · see citing works

Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

Blanco, A., de la Hoya, M., Balmañà, J., y Cajal, T. R., Teulé, À., Miramar, M.-D., Esteban, E., Infante, M., Benitez, J. J., Torres, A., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1842-2 · Cited by 57 · see citing works

The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer

Tapper, W., Hammond, V., Gerty, S. M., Ennis, S., Simmonds, P., Collins, A. R., the Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) Steering Group, & Eccles, D. (2008) · Breast Cancer Research · doi:10.1186/bcr2213 · Cited by 57 · see citing works

DNA double-strand breaks induced by mammographic screening procedures in human mammary epithelial cells

Colin, C., Devic, C., Noël, A., Rabilloud, M., Zabot, M. T., Isaac, S., Giraud, S., Riche, B., Valette, P., Rodriguez‐Lafrasse, C., et al. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.608410 · Cited by 57 · see citing works

Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility

Chen, A.-X., Yu, K., Fan, L., Li, J., Yang, C., Huang, A., & Shao, Z. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002259 · Cited by 56 · see citing works

A Comprehensive Review of Ovarian Serous Carcinoma

Hatano, Y., Hatano, K., Tamada, M., Morishige, K.-I., Tomita, H., Yanai, H., & Hara, A. (2019) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000243 · Cited by 55 · see citing works

PALB2 mutations in German and Russian patients with bilateral breast cancer

Bogdanova, N. V., Соколенко, А. П., Iyevleva, A. G., Алексахина, С. Н., Blaut, M. A., Bremer, M., Christiansen, H., Rave‐Fränk, M., Dörk, T., & Имянитов, Е. Н. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1290-4 · Cited by 53 · see citing works

RASSF1A Polymorphism A133S Is Associated with Early Onset Breast Cancer in BRCA1/2 Mutation Carriers

Gao, B., Xie, X., Huang, C., Shames, D. S., Chen, T. T.-L., Lewis, C. M., Bian, A., Zhang, B., Olopade, O. I., Garber, J. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5183 · Cited by 53 · see citing works

Inherited breast and ovarian cancer

Szabo, C., & King, M. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.suppl_1.1811 · Cited by 202 · see citing works

The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets

García, M. J., & Benitez, J. J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0160-6 · Cited by 34 · see citing works

Tumor suppressor genes and breast cancer

Buchholz, T. A., Weil, M. M., Story, M. D., Strom, E. A., Brock, W. A., & McNeese, M. D. (1999) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1999)7:2 · Cited by 32 · see citing works

Breast Cancer Predisposition Syndromes

Hemel, D., & Domchek, S. M. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.06.004 · Cited by 30 · see citing works

Breast Cancer Gene (BRCA1, BRCA2)

Lee, C. H. (2003) · Journal of Medicine and Life Science · doi:10.22730/jmls.2003.1.1.1